These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 8201547)

  • 21. Tableting of coated particles. I. Small particle size chitosan as an agent protecting coating membrane from mechanical damage of compression force.
    Yao T; Yamada M; Yamahara H; Yoshida M
    Chem Pharm Bull (Tokyo); 1997 Sep; 45(9):1510-4. PubMed ID: 9332004
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mucoadhesive vaginal tablets as veterinary delivery system for the controlled release of an antimicrobial drug, acriflavine.
    Gavini E; Sanna V; Juliano C; Bonferoni MC; Giunchedi P
    AAPS PharmSciTech; 2002; 3(3):E20. PubMed ID: 12916935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chitosan/calcium alginate microcapsules for intestinal delivery of nitrofurantoin.
    Hari PR; Chandy T; Sharma CP
    J Microencapsul; 1996; 13(3):319-29. PubMed ID: 8860687
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In situ cross-linking of sodium alginate with calcium and aluminum ions to sustain the release of theophylline from polymeric matrices.
    Nokhodchi A; Tailor A
    Farmaco; 2004 Dec; 59(12):999-1004. PubMed ID: 15598436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Investigation of Oral Preparation That Is Expected to Improve Medication Administration: Preparation and Evaluation of Oral Gelling Tablet Using Sodium Alginate].
    Ito I; Ito A; Unezaki S
    Yakugaku Zasshi; 2017; 137(8):969-977. PubMed ID: 28768950
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug release characteristics from chitosan-alginate matrix tablets based on the theory of self-assembled film.
    Li L; Wang L; Shao Y; Ni R; Zhang T; Mao S
    Int J Pharm; 2013 Jun; 450(1-2):197-207. PubMed ID: 23624081
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of pH on the in vitro dissolution and in vivo absorption of controlled-release theophylline in dogs.
    Vashi VI; Meyer MC
    J Pharm Sci; 1988 Sep; 77(9):760-4. PubMed ID: 3225770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Formation of water-insoluble gel in dry-coated tablets for the controlled release of theophylline.
    Kaneko K; Kanada K; Miyagi M; Saito N; Ozeki T; Yuasa H; Kanaya Y
    Chem Pharm Bull (Tokyo); 1998 Apr; 46(4):728-9. PubMed ID: 9579051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preparation of an extended-release matrix tablet using chitosan/Carbopol interpolymer complex.
    Park SH; Chun MK; Choi HK
    Int J Pharm; 2008 Jan; 347(1-2):39-44. PubMed ID: 17662544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preparation and evaluation of sustained release calcium alginate beads and matrix tablets of acetazolamide.
    Barzegar-Jalali M; Hanaee J; Omidi Y; Ghanbarzadeh S; Ziaee S; Bairami-Atashgah R; Adibkia K
    Drug Res (Stuttg); 2013 Feb; 63(2):60-4. PubMed ID: 23447074
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral sustained delivery of theophylline using in-situ gelation of sodium alginate.
    Miyazaki S; Kubo W; Attwood D
    J Control Release; 2000 Jul; 67(2-3):275-80. PubMed ID: 10825560
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro release testing of matrices based on starch-methyl methacrylate copolymers: effect of tablet crushing force, dissolution medium pH and stirring rate.
    Ferrero C; Jiménez-Castellanos MR
    Int J Pharm; 2014 Jan; 461(1-2):270-9. PubMed ID: 24333902
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipoinsulin encapsulated alginate-chitosan capsules: intestinal delivery in diabetic rats.
    Ramadas M; Paul W; Dileep KJ; Anitha Y; Sharma CP
    J Microencapsul; 2000; 17(4):405-11. PubMed ID: 10898081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Study of the influence of the pH media dissolution, degree of polymerization, and degree of swelling of the polymers on the mechanism of release of diltiazem from matrices based on mixtures of chitosan/alginate.
    Tapia C; Costa E; Moris M; Sapag-Hagar J; Valenzuela F; Basualto C
    Drug Dev Ind Pharm; 2002; 28(2):217-24. PubMed ID: 11926366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modification of theophylline release with alginate gel formed in hard capsules.
    Sriamornsak P; Sungthongjeen S
    AAPS PharmSciTech; 2007 Jul; 8(3):E51. PubMed ID: 17915801
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sustained-release oral delivery of theophylline by use of polyvinyl alcohol and polyvinyl alcohol-methyl acrylate polymers.
    DiLuccio RC; Hussain MA; Coffin-Beach D; Torosian G; Shefter E; Hurwitz AR
    J Pharm Sci; 1994 Jan; 83(1):104-6. PubMed ID: 8138896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Utility of gastrointestinal physiology regulated-dogs: bioavailability study of a commercial sustained-release dosage form of theophylline.
    Sagara K; Kawata M; Mizuta H; Shibata M
    Biol Pharm Bull; 1994 Jul; 17(7):931-4. PubMed ID: 8000380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Swelling, erosion and release behavior of alginate-based matrix tablets.
    Sriamornsak P; Thirawong N; Korkerd K
    Eur J Pharm Biopharm; 2007 Jun; 66(3):435-50. PubMed ID: 17267187
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In situ gelling xyloglucan/alginate liquid formulation for oral sustained drug delivery to dysphagic patients.
    Itoh K; Tsuruya R; Shimoyama T; Watanabe H; Miyazaki S; D'Emanuele A; Attwood D
    Drug Dev Ind Pharm; 2010 Apr; 36(4):449-55. PubMed ID: 19788404
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Eudraginated polymer blends: a potential oral controlled drug delivery system for theophylline.
    Emeje M; John-Africa L; Isimi Y; Kunle O; Ofoefule S
    Acta Pharm; 2012 Mar; 62(1):71-82. PubMed ID: 22472450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.